Atlas Trials

Study of Paclitaxel Polymeric Micelles Combined With HP and Adebelimab Versus Taxane Combined With HP as First-Line Treatment for Advanced HER2-Positive Breast Cancer

Clinical trial NCT07581795 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07581795
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced HER2-positive Breast Cancer
Start date
2026-06-01
Primary completion
2029-02-01
Enrollment
140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.